180 Life Sciences Corp ATNF shares are trading lower by 18.3% to $0.69 Thursday morning after the company announced pricing of a $3 million public offering.
4,615,385 common stock shares and accompanying warrants will be priced at $0.65 per share. The warrants are exercisable at the same price until October 10, 2028.
The offering is set to close around August 14, subject to customary conditions. The net proceeds will support research, development, general corporate purposes and legal expenses, including preparation for marketing authorization applications for Dupuytren's Contracture.
See Also: U.S. Inflation Misses Estimates
According to data from Benzinga Pro, ATNF has a 52-week high of $23.80 and a 52-week low of $0.66.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
